|
SMCR8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.07029973562112E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.95040003328984E-09 |
| Normal-vs-Stage2 |
7.387300E-04 |
| Normal-vs-Stage3 |
1.12519999984073E-07 |
| Normal-vs-Stage4 |
3.02240000027432E-07 |
| Stage1-vs-Stage2 |
4.742400E-01 |
| Stage1-vs-Stage3 |
5.860600E-01 |
| Stage1-vs-Stage4 |
2.860400E-01 |
| Stage2-vs-Stage3 |
3.306600E-01 |
| Stage2-vs-Stage4 |
1.754160E-01 |
| Stage3-vs-Stage4 |
5.578200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.71119995950875E-09 |
| Normal-vs-AfricanAmerican |
7.223400E-03 |
| Normal-vs-Asian |
1.84259999999048E-05 |
| Caucasian-vs-AfricanAmerican |
2.917800E-01 |
| Caucasian-vs-Asian |
8.673200E-01 |
| AfricanAmerican-vs-Asian |
2.781400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.17949999661948E-09 |
| Normal-vs-Female |
7.79800002348452E-09 |
| Male-vs-Female |
2.689000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.91559999973556E-07 |
| Normal-vs-Age(41-60Yrs) |
5.31080002197371E-09 |
| Normal-vs-Age(61-80Yrs) |
4.7956000004401E-07 |
| Normal-vs-Age(81-100Yrs) |
4.897100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.790400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.981000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.292600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.262400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.592600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.742600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.481600E-01 |
| Classical-VS-Follicular |
6.232200E-02 |
| Classical-VS-Other |
6.710200E-02 |
| Classical-VS-Normal |
5.9004000019236E-08 |
| Tall-VS-Follicular |
9.442400E-01 |
| Tall-VS-Other |
2.093600E-01 |
| Tall-VS-Normal |
3.99660000000024E-05 |
| Follicular-VS-Other |
2.841600E-01 |
| Follicular-VS-Normal |
1.22130000002052E-07 |
| Other-VS-Normal |
1.160080E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.57090000294258E-08 |
| Normal-vs-N1 |
7.7276999999043E-07 |
| N0-vs-N1 |
2.220200E-01 |
|
|
